JP2016526910A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016526910A5 JP2016526910A5 JP2016531871A JP2016531871A JP2016526910A5 JP 2016526910 A5 JP2016526910 A5 JP 2016526910A5 JP 2016531871 A JP2016531871 A JP 2016531871A JP 2016531871 A JP2016531871 A JP 2016531871A JP 2016526910 A5 JP2016526910 A5 JP 2016526910A5
- Authority
- JP
- Japan
- Prior art keywords
- cartridge
- bioprinter
- bio
- ink
- printer head
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000463 material Substances 0.000 claims description 215
- 239000000203 mixture Substances 0.000 claims description 115
- 210000001736 Capillaries Anatomy 0.000 claims description 81
- 238000001125 extrusion Methods 0.000 claims description 38
- 238000000034 method Methods 0.000 claims description 35
- 239000007788 liquid Substances 0.000 claims description 28
- 239000007787 solid Substances 0.000 claims description 27
- 238000006073 displacement reaction Methods 0.000 claims description 19
- 230000001276 controlling effect Effects 0.000 claims description 14
- 238000002360 preparation method Methods 0.000 claims description 13
- 239000008247 solid mixture Substances 0.000 claims description 7
- 238000007641 inkjet printing Methods 0.000 claims description 5
- 238000004891 communication Methods 0.000 claims description 3
- 210000003128 Head Anatomy 0.000 description 281
- 210000004027 cells Anatomy 0.000 description 251
- 239000000976 ink Substances 0.000 description 209
- 210000001519 tissues Anatomy 0.000 description 122
- 239000010410 layer Substances 0.000 description 117
- 210000000056 organs Anatomy 0.000 description 99
- 230000000670 limiting Effects 0.000 description 57
- 239000000017 hydrogel Substances 0.000 description 46
- 239000002609 media Substances 0.000 description 40
- 239000000969 carrier Substances 0.000 description 37
- 239000000499 gel Substances 0.000 description 36
- 238000007639 printing Methods 0.000 description 32
- 239000000243 solution Substances 0.000 description 29
- 239000001963 growth media Substances 0.000 description 27
- 239000006285 cell suspension Substances 0.000 description 22
- -1 supports Substances 0.000 description 21
- 230000001413 cellular Effects 0.000 description 18
- 239000003795 chemical substances by application Substances 0.000 description 17
- 239000011521 glass Substances 0.000 description 17
- 210000002540 Macrophages Anatomy 0.000 description 15
- 238000004519 manufacturing process Methods 0.000 description 14
- 229920001992 poloxamer 407 Polymers 0.000 description 13
- 239000012591 Dulbecco’s Phosphate Buffered Saline Substances 0.000 description 12
- 239000012071 phase Substances 0.000 description 12
- 230000000694 effects Effects 0.000 description 11
- 210000002950 fibroblast Anatomy 0.000 description 11
- 230000004927 fusion Effects 0.000 description 11
- 235000015097 nutrients Nutrition 0.000 description 11
- 239000008188 pellet Substances 0.000 description 11
- 239000003211 photoinitiator Substances 0.000 description 11
- 210000000130 stem cell Anatomy 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- UCSJYZPVAKXKNQ-HZYVHMACSA-N 1-[(1S,2R,3R,4S,5R,6R)-3-carbamimidamido-6-{[(2R,3R,4R,5S)-3-{[(2S,3S,4S,5R,6S)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy}-4-formyl-4-hydroxy-5-methyloxolan-2-yl]oxy}-2,4,5-trihydroxycyclohexyl]guanidine Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 10
- 241000013987 Colletes Species 0.000 description 10
- 210000002889 Endothelial Cells Anatomy 0.000 description 10
- 210000002744 Extracellular Matrix Anatomy 0.000 description 10
- 210000004072 Lung Anatomy 0.000 description 10
- 210000002901 Mesenchymal Stem Cells Anatomy 0.000 description 10
- 108090000631 Trypsin Proteins 0.000 description 10
- 102000004142 Trypsin Human genes 0.000 description 10
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 10
- 229960001322 trypsin Drugs 0.000 description 10
- 239000012588 trypsin Substances 0.000 description 10
- 108010010803 Gelatin Proteins 0.000 description 9
- 210000004185 Liver Anatomy 0.000 description 9
- 229940072056 alginate Drugs 0.000 description 9
- 229920000615 alginic acid Polymers 0.000 description 9
- 235000010443 alginic acid Nutrition 0.000 description 9
- 229920000159 gelatin Polymers 0.000 description 9
- 239000008273 gelatin Substances 0.000 description 9
- 235000019322 gelatine Nutrition 0.000 description 9
- 235000011852 gelatine desserts Nutrition 0.000 description 9
- 230000002792 vascular Effects 0.000 description 9
- 239000004809 Teflon Substances 0.000 description 8
- 238000004220 aggregation Methods 0.000 description 8
- 230000002776 aggregation Effects 0.000 description 8
- 239000006143 cell culture media Substances 0.000 description 8
- 238000004132 cross linking Methods 0.000 description 8
- 230000001965 increased Effects 0.000 description 8
- 230000003287 optical Effects 0.000 description 8
- 229920000642 polymer Polymers 0.000 description 8
- 239000011780 sodium chloride Substances 0.000 description 8
- 239000006228 supernatant Substances 0.000 description 8
- 108010035532 Collagen Proteins 0.000 description 7
- 102000008186 Collagen Human genes 0.000 description 7
- 238000004166 bioassay Methods 0.000 description 7
- 229920001436 collagen Polymers 0.000 description 7
- 229960005188 collagen Drugs 0.000 description 7
- 239000012141 concentrate Substances 0.000 description 7
- 239000002826 coolant Substances 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 239000012091 fetal bovine serum Substances 0.000 description 7
- 230000028993 immune response Effects 0.000 description 7
- 238000003860 storage Methods 0.000 description 7
- 238000002054 transplantation Methods 0.000 description 7
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 6
- 210000003734 Kidney Anatomy 0.000 description 6
- 210000000329 Myocytes, Smooth Muscle Anatomy 0.000 description 6
- 239000000560 biocompatible material Substances 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 230000012010 growth Effects 0.000 description 6
- 230000004957 immunoregulator effect Effects 0.000 description 6
- 239000003018 immunosuppressive agent Substances 0.000 description 6
- 210000004962 mammalian cells Anatomy 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- MYMOFIZGZYHOMD-UHFFFAOYSA-N oxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 6
- 229910052760 oxygen Inorganic materials 0.000 description 6
- 239000001301 oxygen Substances 0.000 description 6
- 229920003023 plastic Polymers 0.000 description 6
- 239000004033 plastic Substances 0.000 description 6
- 238000004904 shortening Methods 0.000 description 6
- 239000000080 wetting agent Substances 0.000 description 6
- GJKGAPPUXSSCFI-UHFFFAOYSA-N 2-hydroxy-1-[4-(2-hydroxyethoxy)phenyl]-2-methylpropan-1-one Chemical compound CC(C)(O)C(=O)C1=CC=C(OCCO)C=C1 GJKGAPPUXSSCFI-UHFFFAOYSA-N 0.000 description 5
- 229920000936 Agarose Polymers 0.000 description 5
- 229940049954 Penicillin Drugs 0.000 description 5
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 5
- 229960005322 Streptomycin Drugs 0.000 description 5
- 229960000626 benzylpenicillin Drugs 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 230000030833 cell death Effects 0.000 description 5
- 238000000151 deposition Methods 0.000 description 5
- 238000007876 drug discovery Methods 0.000 description 5
- 229940014041 hyaluronate Drugs 0.000 description 5
- 239000003112 inhibitor Substances 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 238000006011 modification reaction Methods 0.000 description 5
- 239000002245 particle Substances 0.000 description 5
- 239000002953 phosphate buffered saline Substances 0.000 description 5
- 229920001983 poloxamer Polymers 0.000 description 5
- 238000000926 separation method Methods 0.000 description 5
- 238000010186 staining Methods 0.000 description 5
- 239000010414 supernatant solution Substances 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- 238000011099 tissue engineering Methods 0.000 description 5
- APKFDSVGJQXUKY-INPOYWNPSA-N BRL-49594 Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 description 4
- 210000004369 Blood Anatomy 0.000 description 4
- 210000002808 Connective Tissue Anatomy 0.000 description 4
- JYGXADMDTFJGBT-VWUMJDOOSA-N Cortisol Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 4
- 229950003499 FIBRIN Drugs 0.000 description 4
- 102000009123 Fibrin Human genes 0.000 description 4
- 108010073385 Fibrin Proteins 0.000 description 4
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 4
- 206010052779 Transplant rejections Diseases 0.000 description 4
- 230000001154 acute Effects 0.000 description 4
- 229960003942 amphotericin B Drugs 0.000 description 4
- 102000004965 antibodies Human genes 0.000 description 4
- 108090001123 antibodies Proteins 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 230000001684 chronic Effects 0.000 description 4
- 238000004140 cleaning Methods 0.000 description 4
- 201000009910 diseases by infectious agent Diseases 0.000 description 4
- 229940079593 drugs Drugs 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000001879 gelation Methods 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- 229960000890 hydrocortisone Drugs 0.000 description 4
- 230000002458 infectious Effects 0.000 description 4
- 230000035699 permeability Effects 0.000 description 4
- 229920002401 polyacrylamide Polymers 0.000 description 4
- 229920001888 polyacrylic acid Polymers 0.000 description 4
- 238000006116 polymerization reaction Methods 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 229920001059 synthetic polymer Polymers 0.000 description 4
- 230000035899 viability Effects 0.000 description 4
- 230000000007 visual effect Effects 0.000 description 4
- 206010059512 Apoptosis Diseases 0.000 description 3
- 241000219430 Betula pendula Species 0.000 description 3
- 210000000988 Bone and Bones Anatomy 0.000 description 3
- 210000001671 Embryonic Stem Cells Anatomy 0.000 description 3
- 229940012952 Fibrinogen Drugs 0.000 description 3
- 108010049003 Fibrinogen Proteins 0.000 description 3
- 102000008946 Fibrinogen Human genes 0.000 description 3
- 229940019698 Fibrinogen containing hemostatics Drugs 0.000 description 3
- 229960002897 Heparin Drugs 0.000 description 3
- ZFGMDIBRIDKWMY-PASTXAENSA-N Heparin Chemical compound CC(O)=N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COS(O)(=O)=O)O[C@@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O[C@H]2[C@@H]([C@@H](OS(O)(=O)=O)[C@@H](O[C@@H]3[C@@H](OC(O)[C@H](OS(O)(=O)=O)[C@H]3O)C(O)=O)O[C@@H]2O)CS(O)(=O)=O)[C@H](O)[C@H]1O ZFGMDIBRIDKWMY-PASTXAENSA-N 0.000 description 3
- 210000002220 Organoids Anatomy 0.000 description 3
- 229960000502 Poloxamer Drugs 0.000 description 3
- 239000004698 Polyethylene (PE) Substances 0.000 description 3
- 210000002966 Serum Anatomy 0.000 description 3
- 210000003283 T-Lymphocytes, Helper-Inducer Anatomy 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 239000000427 antigen Substances 0.000 description 3
- 102000038129 antigens Human genes 0.000 description 3
- 108091007172 antigens Proteins 0.000 description 3
- 230000006907 apoptotic process Effects 0.000 description 3
- UIIMBOGNXHQVGW-UHFFFAOYSA-M buffer Substances [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 3
- 238000004113 cell culture Methods 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000007906 compression Methods 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 238000005520 cutting process Methods 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 238000009792 diffusion process Methods 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000005755 formation reaction Methods 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 229920000669 heparin Polymers 0.000 description 3
- 101500002601 human Epidermal growth factor Proteins 0.000 description 3
- 229940116978 human epidermal growth factor Drugs 0.000 description 3
- 230000002209 hydrophobic Effects 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 239000003999 initiator Substances 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 230000003278 mimic Effects 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 229920005615 natural polymer Polymers 0.000 description 3
- 230000001264 neutralization Effects 0.000 description 3
- 210000004738 parenchymal cell Anatomy 0.000 description 3
- 229920000573 polyethylene Polymers 0.000 description 3
- 229920005862 polyol Polymers 0.000 description 3
- 150000003077 polyols Chemical class 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- CIWBSHSKHKDKBQ-DUZGATOHSA-N (+)-Ascorbic acid Natural products OC[C@@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-DUZGATOHSA-N 0.000 description 2
- 229920002818 (Hydroxyethyl)methacrylate Polymers 0.000 description 2
- WOBHKFSMXKNTIM-UHFFFAOYSA-N 2-hydroxyethyl 2-methylacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 2
- 210000004504 Adult Stem Cells Anatomy 0.000 description 2
- 206010059245 Angiopathy Diseases 0.000 description 2
- 241000416162 Astragalus gummifer Species 0.000 description 2
- 210000004204 Blood Vessels Anatomy 0.000 description 2
- 230000036099 Cav Effects 0.000 description 2
- 241000725585 Chicken anemia virus Species 0.000 description 2
- 229920001661 Chitosan Polymers 0.000 description 2
- 210000001612 Chondrocytes Anatomy 0.000 description 2
- 102000004127 Cytokines Human genes 0.000 description 2
- 108090000695 Cytokines Proteins 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N D-Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 210000003981 Ectoderm Anatomy 0.000 description 2
- 108010014258 Elastin Proteins 0.000 description 2
- 102000016942 Elastin Human genes 0.000 description 2
- 210000001900 Endoderm Anatomy 0.000 description 2
- 210000000981 Epithelium Anatomy 0.000 description 2
- 229910052693 Europium Inorganic materials 0.000 description 2
- 102000003974 Fibroblast Growth Factor 2 Human genes 0.000 description 2
- 108090000379 Fibroblast Growth Factor 2 Proteins 0.000 description 2
- 108010067306 Fibronectins Proteins 0.000 description 2
- 102000016359 Fibronectins Human genes 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- 102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 description 2
- 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 description 2
- JKMHFZQWWAIEOD-UHFFFAOYSA-N HEPES Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 2
- 239000007995 HEPES buffer Substances 0.000 description 2
- 210000002216 Heart Anatomy 0.000 description 2
- 229940099552 Hyaluronan Drugs 0.000 description 2
- KIUKXJAPPMFGSW-MNSSHETKSA-N Hyaluronan Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-MNSSHETKSA-N 0.000 description 2
- 210000004263 Induced Pluripotent Stem Cells Anatomy 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- 239000002211 L-ascorbic acid Substances 0.000 description 2
- TYQCGQRIZGCHNB-JLAZNSOCSA-N L-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(O)=C(O)C1=O TYQCGQRIZGCHNB-JLAZNSOCSA-N 0.000 description 2
- 235000000069 L-ascorbic acid Nutrition 0.000 description 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 2
- 108010085895 Laminin Proteins 0.000 description 2
- 102000007547 Laminin Human genes 0.000 description 2
- 241000712899 Lymphocytic choriomeningitis mammarenavirus Species 0.000 description 2
- 229920002521 Macromolecule Polymers 0.000 description 2
- 210000003716 Mesoderm Anatomy 0.000 description 2
- 208000005384 Pneumocystis Pneumonia Diseases 0.000 description 2
- 206010073755 Pneumocystis jirovecii pneumonia Diseases 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 108010067787 Proteoglycans Proteins 0.000 description 2
- 210000001147 Pulmonary Artery Anatomy 0.000 description 2
- 239000004231 Riboflavin-5-Sodium Phosphate Substances 0.000 description 2
- 210000000952 Spleen Anatomy 0.000 description 2
- 229940116362 Tragacanth Drugs 0.000 description 2
- 229920001615 Tragacanth Polymers 0.000 description 2
- 210000003932 Urinary Bladder Anatomy 0.000 description 2
- 230000003213 activating Effects 0.000 description 2
- 235000004279 alanine Nutrition 0.000 description 2
- 210000003663 amniotic stem cell Anatomy 0.000 description 2
- 230000002424 anti-apoptotic Effects 0.000 description 2
- 230000003078 antioxidant Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 210000002403 aortic endothelial cell Anatomy 0.000 description 2
- 210000003433 aortic smooth muscle cell Anatomy 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 238000006065 biodegradation reaction Methods 0.000 description 2
- 239000012472 biological sample Substances 0.000 description 2
- 230000036760 body temperature Effects 0.000 description 2
- 210000003678 bronchial smooth muscle cell Anatomy 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L cacl2 Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- 230000017455 cell-cell adhesion Effects 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 230000000295 complement Effects 0.000 description 2
- 230000001143 conditioned Effects 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 230000000875 corresponding Effects 0.000 description 2
- 210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 2
- 125000004386 diacrylate group Chemical group 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 229920002549 elastin Polymers 0.000 description 2
- 230000005684 electric field Effects 0.000 description 2
- OGPBJKLSAFTDLK-UHFFFAOYSA-N europium Chemical compound [Eu] OGPBJKLSAFTDLK-UHFFFAOYSA-N 0.000 description 2
- 230000037320 fibronectin Effects 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 230000002496 gastric Effects 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 230000001788 irregular Effects 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 108010082117 matrigel Proteins 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 230000035800 maturation Effects 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000005012 migration Effects 0.000 description 2
- 230000000877 morphologic Effects 0.000 description 2
- 239000002121 nanofiber Substances 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 238000000059 patterning Methods 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 201000000317 pneumocystosis Diseases 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 229920000747 poly(lactic acid) polymer Polymers 0.000 description 2
- 229920002627 poly(phosphazenes) Polymers 0.000 description 2
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000000541 pulsatile Effects 0.000 description 2
- 230000002829 reduced Effects 0.000 description 2
- 230000001172 regenerating Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 231100000486 side effect Toxicity 0.000 description 2
- 230000011664 signaling Effects 0.000 description 2
- 230000001954 sterilising Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 230000002194 synthesizing Effects 0.000 description 2
- 229920000208 temperature-responsive polymer Polymers 0.000 description 2
- 230000001225 therapeutic Effects 0.000 description 2
- 239000000196 tragacanth Substances 0.000 description 2
- 235000010487 tragacanth Nutrition 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- 239000002023 wood Substances 0.000 description 2
- QNODIIQQMGDSEF-UHFFFAOYSA-N (1-hydroxycyclohexyl)-phenylmethanone Chemical compound C=1C=CC=CC=1C(=O)C1(O)CCCCC1 QNODIIQQMGDSEF-UHFFFAOYSA-N 0.000 description 1
- NKCXQMYPWXSLIZ-PSRDDEIFSA-N (2S)-2-[[(2S)-1-[(2S)-5-amino-2-[[2-[[(2S)-6-amino-2-[[2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3R)-2-amino-3-hydroxybutanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-3-hydroxybutanoyl]amino]propanoyl]amino]-4-oxobutanoyl]amino]-3-m Chemical compound O=C([C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)O)C(C)C)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O NKCXQMYPWXSLIZ-PSRDDEIFSA-N 0.000 description 1
- PMATZTZNYRCHOR-CGLBZJNRSA-N (3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17 Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 1
- KWVGIHKZDCUPEU-UHFFFAOYSA-N 2,2-Dimethoxy-2-phenylacetophenone Chemical compound C=1C=CC=CC=1C(OC)(OC)C(=O)C1=CC=CC=C1 KWVGIHKZDCUPEU-UHFFFAOYSA-N 0.000 description 1
- 101710027066 ALB Proteins 0.000 description 1
- 102100001249 ALB Human genes 0.000 description 1
- 102000007469 Actins Human genes 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 210000002534 Adenoids Anatomy 0.000 description 1
- 210000000577 Adipose Tissue Anatomy 0.000 description 1
- 210000004100 Adrenal Glands Anatomy 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 229960002170 Azathioprine Drugs 0.000 description 1
- 229910016066 BaSi Inorganic materials 0.000 description 1
- 108010067213 Basiliximab Proteins 0.000 description 1
- 210000000601 Blood Cells Anatomy 0.000 description 1
- 210000004556 Brain Anatomy 0.000 description 1
- 210000000621 Bronchi Anatomy 0.000 description 1
- 229940046731 Calcineurin inhibitors Drugs 0.000 description 1
- 108010067225 Cell Adhesion Molecules Proteins 0.000 description 1
- 102000016289 Cell Adhesion Molecules Human genes 0.000 description 1
- 229910052684 Cerium Inorganic materials 0.000 description 1
- 201000003884 Chagas disease Diseases 0.000 description 1
- 210000001072 Colon Anatomy 0.000 description 1
- 210000001608 Connective Tissue Cells Anatomy 0.000 description 1
- 229940064701 Corticosteroid nasal preparations for topical use Drugs 0.000 description 1
- 229960001334 Corticosteroids Drugs 0.000 description 1
- 208000003407 Creutzfeldt-Jakob Syndrome Diseases 0.000 description 1
- 201000010450 Creutzfeldt-Jakob disease Diseases 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- 229940119017 Cyclosporine Drugs 0.000 description 1
- 108010036949 Cyclosporine Proteins 0.000 description 1
- 241000701022 Cytomegalovirus Species 0.000 description 1
- 210000000805 Cytoplasm Anatomy 0.000 description 1
- 108010084740 Daclizumab Proteins 0.000 description 1
- 101700057458 Drice Proteins 0.000 description 1
- 206010058108 Dyslipidaemia Diseases 0.000 description 1
- 210000004177 Elastic Tissue Anatomy 0.000 description 1
- 210000003238 Esophagus Anatomy 0.000 description 1
- HKVAMNSJSFKALM-WDSGEKFTSA-N Everolimus Chemical compound C1C[C@@H](OCCO)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)\C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 HKVAMNSJSFKALM-WDSGEKFTSA-N 0.000 description 1
- 210000001723 Extracellular Space Anatomy 0.000 description 1
- 241000272184 Falconiformes Species 0.000 description 1
- 102000013361 Fetuins Human genes 0.000 description 1
- 108060002885 Fetuins Proteins 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 210000000232 Gallbladder Anatomy 0.000 description 1
- 229940014259 Gelatin Drugs 0.000 description 1
- 210000004907 Glands Anatomy 0.000 description 1
- 210000003709 Heart Valves Anatomy 0.000 description 1
- 208000005176 Hepatitis C Diseases 0.000 description 1
- 210000003494 Hepatocytes Anatomy 0.000 description 1
- 208000009889 Herpes Simplex Diseases 0.000 description 1
- 208000007514 Herpes Zoster Diseases 0.000 description 1
- 240000008528 Hevea brasiliensis Species 0.000 description 1
- 229940088597 Hormone Drugs 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 210000003016 Hypothalamus Anatomy 0.000 description 1
- 229940072221 IMMUNOGLOBULINS Drugs 0.000 description 1
- 229960003444 IMMUNOSUPPRESSANTS Drugs 0.000 description 1
- 210000000987 Immune System Anatomy 0.000 description 1
- 108060003951 Immunoglobulins Proteins 0.000 description 1
- 102000018358 Immunoglobulins Human genes 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- 102000008986 Janus Human genes 0.000 description 1
- 108050000950 Janus Proteins 0.000 description 1
- 210000001847 Jaw Anatomy 0.000 description 1
- 210000000867 Larynx Anatomy 0.000 description 1
- 206010061227 Lipid metabolism disease Diseases 0.000 description 1
- 210000001365 Lymphatic Vessels Anatomy 0.000 description 1
- 210000004698 Lymphocytes Anatomy 0.000 description 1
- 210000003563 Lymphoid Tissue Anatomy 0.000 description 1
- 101700067074 MAPK Proteins 0.000 description 1
- 101710041325 MAPKAPK2 Proteins 0.000 description 1
- 102000009571 Macrophage Inflammatory Proteins Human genes 0.000 description 1
- 108010009474 Macrophage Inflammatory Proteins Proteins 0.000 description 1
- 210000002264 Mammary Glands, Animal Anatomy 0.000 description 1
- 210000004293 Mammary Glands, Human Anatomy 0.000 description 1
- 210000004175 Meibomian Glands Anatomy 0.000 description 1
- 102000005741 Metalloproteases Human genes 0.000 description 1
- 108010006035 Metalloproteases Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 210000003097 Mucus Anatomy 0.000 description 1
- 210000002027 Muscle, Skeletal Anatomy 0.000 description 1
- 210000002464 Muscle, Smooth, Vascular Anatomy 0.000 description 1
- 210000003205 Muscles Anatomy 0.000 description 1
- 229960000951 Mycophenolic Acid Drugs 0.000 description 1
- 210000001057 Myoblasts, Smooth Muscle Anatomy 0.000 description 1
- 210000004165 Myocardium Anatomy 0.000 description 1
- 210000004413 Myocytes, Cardiac Anatomy 0.000 description 1
- 206010029803 Nosocomial infection Diseases 0.000 description 1
- 210000001672 Ovary Anatomy 0.000 description 1
- 210000003101 Oviducts Anatomy 0.000 description 1
- 210000002741 Palatine Tonsil Anatomy 0.000 description 1
- 210000000496 Pancreas Anatomy 0.000 description 1
- 210000002990 Parathyroid Glands Anatomy 0.000 description 1
- 210000003681 Parotid Gland Anatomy 0.000 description 1
- 208000008469 Peptic Ulcer Diseases 0.000 description 1
- 108091000081 Phosphotransferases Proteins 0.000 description 1
- 102000030951 Phosphotransferases Human genes 0.000 description 1
- 210000004560 Pineal Gland Anatomy 0.000 description 1
- 210000003635 Pituitary Gland Anatomy 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 229940044476 Poloxamer 407 Drugs 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920001451 Polypropylene glycol Polymers 0.000 description 1
- XOFYZVNMUHMLCC-ZPOLXVRWSA-N Prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 description 1
- 210000002307 Prostate Anatomy 0.000 description 1
- 239000007759 RPMI Media 1640 Substances 0.000 description 1
- 206010037742 Rabies Diseases 0.000 description 1
- 101710009384 SRC Proteins 0.000 description 1
- 102000001332 SRC Human genes 0.000 description 1
- 210000003079 Salivary Glands Anatomy 0.000 description 1
- 210000004116 Schwann Cells Anatomy 0.000 description 1
- 210000001732 Sebaceous Glands Anatomy 0.000 description 1
- 102000003800 Selectins Human genes 0.000 description 1
- 108090000184 Selectins Proteins 0.000 description 1
- 241000580858 Simian-Human immunodeficiency virus Species 0.000 description 1
- QFJCIRLUMZQUOT-HPLJOQBZSA-N Sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 description 1
- 210000003491 Skin Anatomy 0.000 description 1
- 210000004927 Skin cells Anatomy 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 210000002784 Stomach Anatomy 0.000 description 1
- 210000002536 Stromal Cells Anatomy 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 210000000106 Sweat Glands Anatomy 0.000 description 1
- 229960001967 Tacrolimus Drugs 0.000 description 1
- QJJXYPPXXYFBGM-LFZNUXCKSA-N Tacrolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1\C=C(/C)[C@@H]1[C@H](C)[C@@H](O)CC(=O)[C@H](CC=C)/C=C(C)/C[C@H](C)C[C@H](OC)[C@H]([C@H](C[C@H]2C)OC)O[C@@]2(O)C(=O)C(=O)N2CCCC[C@H]2C(=O)O1 QJJXYPPXXYFBGM-LFZNUXCKSA-N 0.000 description 1
- 210000001550 Testis Anatomy 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- 210000001541 Thymus Gland Anatomy 0.000 description 1
- 210000001685 Thyroid Gland Anatomy 0.000 description 1
- 210000003437 Trachea Anatomy 0.000 description 1
- 102000004338 Transferrin Human genes 0.000 description 1
- 108090000901 Transferrin Proteins 0.000 description 1
- 102000009618 Transforming Growth Factors Human genes 0.000 description 1
- 108010009583 Transforming Growth Factors Proteins 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Tris Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 241000223109 Trypanosoma cruzi Species 0.000 description 1
- 210000000626 Ureter Anatomy 0.000 description 1
- 210000003708 Urethra Anatomy 0.000 description 1
- 210000004291 Uterus Anatomy 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229940088594 Vitamin Drugs 0.000 description 1
- 241000710886 West Nile virus Species 0.000 description 1
- 241000907138 Xanthomonas oryzae pv. oryzae Species 0.000 description 1
- 101700047982 YAML Proteins 0.000 description 1
- 239000003082 abrasive agent Substances 0.000 description 1
- 230000032912 absorption of UV light Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M acrylate group Chemical group C(C=C)(=O)[O-] NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 230000004931 aggregating Effects 0.000 description 1
- 239000000556 agonist Substances 0.000 description 1
- 229940050528 albumin Drugs 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminum Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- IEPNMLJMIRCTIV-UHFFFAOYSA-H aluminum;lithium;strontium;hexafluoride Chemical compound [Li+].[F-].[F-].[F-].[F-].[F-].[F-].[Al+3].[Sr+2] IEPNMLJMIRCTIV-UHFFFAOYSA-H 0.000 description 1
- WMGSQTMJHBYJMQ-UHFFFAOYSA-N aluminum;magnesium;silicate Chemical compound [Mg+2].[Al+3].[O-][Si]([O-])([O-])[O-] WMGSQTMJHBYJMQ-UHFFFAOYSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000019552 anatomical structure morphogenesis Effects 0.000 description 1
- 230000000781 anti-lymphocytic Effects 0.000 description 1
- 230000001028 anti-proliferant Effects 0.000 description 1
- 230000001494 anti-thymocyte Effects 0.000 description 1
- 210000004618 arterial endothelial cell Anatomy 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000003416 augmentation Effects 0.000 description 1
- 230000003190 augmentative Effects 0.000 description 1
- 230000006877 autophagy Effects 0.000 description 1
- LMEKQMALGUDUQG-UHFFFAOYSA-N azathioprine Chemical compound CN1C=NC([N+]([O-])=O)=C1SC1=NC=NC2=C1NC=N2 LMEKQMALGUDUQG-UHFFFAOYSA-N 0.000 description 1
- 229910052916 barium silicate Inorganic materials 0.000 description 1
- HMOQPOVBDRFNIU-UHFFFAOYSA-N barium(2+);dioxido(oxo)silane Chemical compound [Ba+2].[O-][Si]([O-])=O HMOQPOVBDRFNIU-UHFFFAOYSA-N 0.000 description 1
- 229960004669 basiliximab Drugs 0.000 description 1
- 230000000975 bioactive Effects 0.000 description 1
- 230000003115 biocidal Effects 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 230000000903 blocking Effects 0.000 description 1
- 210000002449 bone cell Anatomy 0.000 description 1
- 210000002798 bone marrow cell Anatomy 0.000 description 1
- 210000004271 bone marrow stromal cells Anatomy 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000007975 buffered saline Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 210000002317 cardiac myocyte Anatomy 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 230000004956 cell adhesive effect Effects 0.000 description 1
- 230000022534 cell killing Effects 0.000 description 1
- 230000025611 cell-substrate adhesion Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- GWXLDORMOJMVQZ-UHFFFAOYSA-N cerium Chemical compound [Ce] GWXLDORMOJMVQZ-UHFFFAOYSA-N 0.000 description 1
- 238000010382 chemical cross-linking Methods 0.000 description 1
- 230000012085 chronic inflammatory response Effects 0.000 description 1
- 229960001265 ciclosporin Drugs 0.000 description 1
- 239000008119 colloidal silica Substances 0.000 description 1
- 230000001010 compromised Effects 0.000 description 1
- 231100000078 corrosive Toxicity 0.000 description 1
- 231100001010 corrosive Toxicity 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 238000009295 crossflow filtration Methods 0.000 description 1
- 238000010192 crystallographic characterization Methods 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 229960002806 daclizumab Drugs 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 238000007877 drug screening Methods 0.000 description 1
- 230000005670 electromagnetic radiation Effects 0.000 description 1
- 210000002308 embryonic cell Anatomy 0.000 description 1
- 230000003511 endothelial Effects 0.000 description 1
- 230000002708 enhancing Effects 0.000 description 1
- 230000002255 enzymatic Effects 0.000 description 1
- 210000002919 epithelial cells Anatomy 0.000 description 1
- 229960005167 everolimus Drugs 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 210000004602 germ cell Anatomy 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 238000010562 histological examination Methods 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000002519 immonomodulatory Effects 0.000 description 1
- 230000001861 immunosuppresant Effects 0.000 description 1
- 238000000099 in vitro assay Methods 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 102000006495 integrins Human genes 0.000 description 1
- 108010044426 integrins Proteins 0.000 description 1
- 230000002452 interceptive Effects 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 210000003292 kidney cell Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000004301 light adaptation Effects 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 230000003211 malignant Effects 0.000 description 1
- 239000003628 mammalian target of rapamycin inhibitor Substances 0.000 description 1
- 230000001404 mediated Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 229910001092 metal group alloy Inorganic materials 0.000 description 1
- 231100000324 minimal toxicity Toxicity 0.000 description 1
- 239000006956 minimum essential medium Substances 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 239000002365 multiple layer Substances 0.000 description 1
- 210000000663 muscle cells Anatomy 0.000 description 1
- HPNSFSBZBAHARI-RUDMXATFSA-N mycophenolic acid Chemical compound OC1=C(C\C=C(/C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-RUDMXATFSA-N 0.000 description 1
- 229920001194 natural rubber Polymers 0.000 description 1
- 239000006199 nebulizer Substances 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000001537 neural Effects 0.000 description 1
- 210000002569 neurons Anatomy 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 229910000480 nickel oxide Inorganic materials 0.000 description 1
- 230000002020 noncytotoxic Effects 0.000 description 1
- 231100000065 noncytotoxic Toxicity 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 230000000474 nursing Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 230000004768 organ dysfunction Effects 0.000 description 1
- 210000000963 osteoblast Anatomy 0.000 description 1
- 230000000790 osteoblast Effects 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N oxane Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- GNRSAWUEBMWBQH-UHFFFAOYSA-N oxonickel Chemical compound [Ni]=O GNRSAWUEBMWBQH-UHFFFAOYSA-N 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 210000003668 pericytes Anatomy 0.000 description 1
- 238000005020 pharmaceutical industry Methods 0.000 description 1
- 238000006068 polycondensation reaction Methods 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000004848 polyfunctional curative Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 229960004618 prednisone Drugs 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 230000004952 protein activity Effects 0.000 description 1
- 230000002685 pulmonary Effects 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 238000006862 quantum yield reaction Methods 0.000 description 1
- 238000003847 radiation curing Methods 0.000 description 1
- 238000010188 recombinant method Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000717 retained Effects 0.000 description 1
- 238000000518 rheometry Methods 0.000 description 1
- 101710024887 rl Proteins 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 238000001338 self-assembly Methods 0.000 description 1
- 239000012056 semi-solid material Substances 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229960002930 sirolimus Drugs 0.000 description 1
- 210000002363 skeletal muscle cell Anatomy 0.000 description 1
- 210000001626 skin fibroblast Anatomy 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 230000003381 solubilizing Effects 0.000 description 1
- 101700045897 spk-1 Proteins 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000003068 static Effects 0.000 description 1
- PVSFXPZNCSBZDI-UHFFFAOYSA-N strontium;ditetrafluoroborate Chemical compound [Sr+2].F[B-](F)(F)F.F[B-](F)(F)F PVSFXPZNCSBZDI-UHFFFAOYSA-N 0.000 description 1
- 125000003011 styrenyl group Chemical group [H]\C(*)=C(/[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 108010053226 substrate adhesion molecules Proteins 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- 239000003104 tissue culture media Substances 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 229940083878 topical for treatment of hemorrhoids and anal fissures Corticosteroids Drugs 0.000 description 1
- 239000012581 transferrin Substances 0.000 description 1
- 229920000428 triblock copolymer Polymers 0.000 description 1
- LNSYCBFBTCINRL-UHFFFAOYSA-N tristrontium;diborate Chemical compound [Sr+2].[Sr+2].[Sr+2].[O-]B([O-])[O-].[O-]B([O-])[O-] LNSYCBFBTCINRL-UHFFFAOYSA-N 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 229930003231 vitamins Natural products 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361860644P | 2013-07-31 | 2013-07-31 | |
| US61/860,644 | 2013-07-31 | ||
| PCT/US2014/048962 WO2015017579A1 (en) | 2013-07-31 | 2014-07-30 | Automated devices, systems, and methods for the fabrication of tissue |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020202047A Division JP2021061839A (ja) | 2013-07-31 | 2020-12-04 | 組織の作製のための自動化デバイス、システム、および方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016526910A JP2016526910A (ja) | 2016-09-08 |
| JP2016526910A5 true JP2016526910A5 (de) | 2018-12-20 |
| JP6842918B2 JP6842918B2 (ja) | 2021-03-17 |
Family
ID=52427884
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016531871A Active JP6842918B2 (ja) | 2013-07-31 | 2014-07-30 | 組織の作製のための自動化デバイス、システム、および方法 |
| JP2020202047A Withdrawn JP2021061839A (ja) | 2013-07-31 | 2020-12-04 | 組織の作製のための自動化デバイス、システム、および方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020202047A Withdrawn JP2021061839A (ja) | 2013-07-31 | 2020-12-04 | 組織の作製のための自動化デバイス、システム、および方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (4) | US20150037445A1 (de) |
| EP (1) | EP3028042B1 (de) |
| JP (2) | JP6842918B2 (de) |
| KR (1) | KR20160036619A (de) |
| CN (1) | CN105659089B (de) |
| AU (1) | AU2014296246B2 (de) |
| BR (1) | BR112016002149A2 (de) |
| CA (1) | CA2919734C (de) |
| DK (1) | DK3028042T3 (de) |
| SG (1) | SG11201600770RA (de) |
| WO (1) | WO2015017579A1 (de) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6991218B2 (ja) | 2016-12-14 | 2022-01-12 | デュール システムズ アーゲー | 塗布装置及びコーティング組成物を塗布する方法 |
Families Citing this family (142)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005081970A2 (en) | 2004-02-24 | 2005-09-09 | The Curators Of The University Of Missouri | Self-assembling cell aggregates and methods of making engineered tissue using the same |
| AU2009271223B2 (en) | 2008-06-24 | 2013-05-16 | The Curators Of The University Of Missouri | Self-assembling multicellular bodies and methods of producing a three-dimensional biological structure using the same |
| US9149952B2 (en) | 2010-10-21 | 2015-10-06 | Organovo, Inc. | Devices, systems, and methods for the fabrication of tissue |
| US9499779B2 (en) | 2012-04-20 | 2016-11-22 | Organovo, Inc. | Devices, systems, and methods for the fabrication of tissue utilizing UV cross-linking |
| EP2943205B1 (de) | 2013-01-14 | 2018-08-22 | Scripps Health | Gewebe-array-drucken |
| US9442105B2 (en) | 2013-03-15 | 2016-09-13 | Organovo, Inc. | Engineered liver tissues, arrays thereof, and methods of making the same |
| DK3028042T3 (da) | 2013-07-31 | 2021-10-04 | Organovo Inc | Automatiserede anordninger, systemer og fremgangsmåder til fremstilling af væv |
| US11903612B2 (en) * | 2013-11-04 | 2024-02-20 | University Of Iowa Research Foundation | Bioprinter and methods of using same |
| US9895847B2 (en) * | 2013-11-27 | 2018-02-20 | Solidscape, Inc. | Method and apparatus for fabricating three dimensional models |
| US20160325499A1 (en) * | 2014-01-05 | 2016-11-10 | David Muller | Systems and methods for producing and applying tissue-related structures |
| KR20170003918A (ko) * | 2014-03-25 | 2017-01-10 | 바이오보츠 인코포레이티드 | 전자기 방사선을 이용한 조직 및 재료의 제조를 위한 방법, 장치, 및 시스템 |
| AU2014389440A1 (en) | 2014-04-04 | 2016-10-20 | Oregon Health & Science University | Engineered three-dimensional breast tissue, adipose tissue, and tumor disease model |
| US9360422B2 (en) * | 2014-05-13 | 2016-06-07 | Asl Analytical, Inc. | Near-infrared optical probe and associated disposable sheath |
| RU2017110275A (ru) | 2014-10-06 | 2018-11-15 | Органово, Инк. | Сконструированные ткани почки, матрицы на их основе и способы их получения |
| US20160122723A1 (en) | 2014-11-05 | 2016-05-05 | Organovo, Inc. | Engineered three-dimensional skin tissues, arrays thereof, and methods of making the same |
| CN105643922B (zh) * | 2014-11-13 | 2018-01-02 | 三纬国际立体列印科技股份有限公司 | 立体打印装置 |
| GB201420265D0 (en) * | 2014-11-14 | 2014-12-31 | The Technology Partnership Plc | Mixer apparatus and system |
| US10414092B2 (en) * | 2015-02-09 | 2019-09-17 | Voltera Inc. | Interchangeable fabrication head assembly |
| US10661504B2 (en) | 2015-03-02 | 2020-05-26 | Funfare, Llc | Three dimensional printer and cartridge |
| JP6807853B2 (ja) * | 2015-03-03 | 2021-01-06 | プレジデント アンド フェローズ オブ ハーバード カレッジ | 機能的ヒト組織の作製方法 |
| CN104726332B (zh) * | 2015-03-05 | 2016-11-16 | 西安交通大学 | 一种类脑组织体外打印培养系统及方法 |
| US20160318260A1 (en) * | 2015-04-30 | 2016-11-03 | Elwha Llc | Printing systems and related methods |
| USD760825S1 (en) | 2015-03-25 | 2016-07-05 | Biobots, Inc. | Bioprinter |
| KR102311639B1 (ko) * | 2015-03-26 | 2021-10-12 | 주식회사 티앤알바이오팹 | 심근조직 재생용 3차원 구조체의 제조방법 |
| US11149240B2 (en) * | 2015-03-31 | 2021-10-19 | Revotek Co., Ltd | Rotary device for bio-printing and method for using the same |
| DK3280463T3 (da) * | 2015-04-07 | 2021-08-02 | Revotek Co Ltd | Sammensætninger til celle-baseret tredimensionel printning |
| TWI741980B (zh) * | 2015-04-07 | 2021-10-11 | 大陸商四川藍光英諾生物科技股份有限公司 | 一種生物磚及其用途 |
| AU2016279941A1 (en) | 2015-06-16 | 2018-01-18 | Aspect Biosystems Ltd. | Continuously bioprinted multilayer tissue structure |
| CN105125316B (zh) * | 2015-07-14 | 2017-03-01 | 武汉大学 | 基于激光诱导的3d生物打印系统及方法 |
| JP6791960B2 (ja) * | 2015-07-22 | 2020-11-25 | インベンティア ライフ サイエンス プロプライアタリー リミティド | ３ｄ組織培養モデルの印刷方法 |
| WO2017023865A1 (en) | 2015-07-31 | 2017-02-09 | Techshot, Inc. | Biomanufacturing system, method, and 3d bioprinting hardware in a reduced gravity environment |
| US11788042B2 (en) | 2015-07-31 | 2023-10-17 | Redwire Space Technologies, Inc. | Biomanufacturing system, method, and 3D bioprinting hardware in a reduced gravity environment |
| US20150343565A1 (en) * | 2015-08-12 | 2015-12-03 | Caterpillar Inc. | Method of forming feature on tube |
| WO2017035007A1 (en) * | 2015-08-21 | 2017-03-02 | Voxel8, Inc. | Calibration and alignment of additive manufacturing deposition heads |
| WO2017040675A1 (en) * | 2015-08-31 | 2017-03-09 | Cellink Ab | Clean chamber technology for 3d printers and bioprinters |
| WO2017040975A1 (en) * | 2015-09-04 | 2017-03-09 | The General Hospital Corporation | Three dimensional microtissue bioprinter |
| WO2017062874A1 (en) | 2015-10-09 | 2017-04-13 | Deka Products Limited Partnership | Fluid pumping and bioreactor system |
| US10395561B2 (en) | 2015-12-07 | 2019-08-27 | Humanetics Innovative Solutions, Inc. | Three-dimensionally printed internal organs for crash test dummy |
| US10733911B2 (en) | 2015-10-14 | 2020-08-04 | Humanetics Innovative Solutions, Inc. | Three-dimensional ribs and method of three-dimensional printing of ribs for crash test dummy |
| TWI593547B (zh) * | 2015-11-13 | 2017-08-01 | 財團法人工業技術研究院 | 三維組織列印裝置、三維組織列印方法及人工皮膚 |
| US20180369451A1 (en) * | 2015-11-20 | 2018-12-27 | Organovo, Inc. | Rotating device and method for continuous fabrication of long biological tubes |
| CN105524831B (zh) * | 2015-12-29 | 2017-09-12 | 西安交通大学 | 一种生物3d打印培养一体化系统及方法 |
| WO2017113157A1 (zh) | 2015-12-30 | 2017-07-06 | 四川蓝光英诺生物科技股份有限公司 | 生物打印机及其校准方法 |
| CN105662648B (zh) * | 2015-12-30 | 2017-07-04 | 四川蓝光英诺生物科技股份有限公司 | 生物打印机及其校准方法 |
| EP3398780A4 (de) * | 2015-12-30 | 2019-08-14 | Revotek Co., Ltd | Temperatursteuerungssystem und -verfahren für biodrucker und biodrucker |
| KR101697738B1 (ko) * | 2016-01-07 | 2017-01-18 | 주식회사 티앤알바이오팹 | 세포 프린팅 장치 |
| US10934538B2 (en) | 2016-01-12 | 2021-03-02 | Cleveland State University | 3D-printed miniature biological constructs |
| US11097532B2 (en) * | 2016-02-01 | 2021-08-24 | Ricoh Company, Ltd. | Method for making mold, method for molding model material, and mold making apparatus |
| JP6874349B2 (ja) * | 2016-02-01 | 2021-05-19 | 株式会社リコー | 鋳型の作成方法及び鋳型作成装置、並びにモデル材の成型方法 |
| KR20170124972A (ko) | 2016-05-03 | 2017-11-13 | 주식회사 티앤알바이오팹 | 삼차원 프린팅용 잉크를 공급하는 방법 및 이를 이용한 삼차원 프린팅 방법 |
| WO2017192004A1 (ko) * | 2016-05-03 | 2017-11-09 | 주식회사 티앤알바이오팹 | 삼차원 프린팅용 잉크를 공급하는 방법 및 이를 이용한 삼차원 프린팅 방법 |
| US10888428B2 (en) * | 2016-05-12 | 2021-01-12 | University Of Notre Dame Du Lac | Additive manufacturing device for biomaterials |
| US10926454B2 (en) * | 2016-05-20 | 2021-02-23 | Sartorius Stedim Biotech Gmbh | Dispensing device and system for biological products |
| EP3463169B1 (de) | 2016-05-26 | 2023-07-19 | Scripps Health | Systeme zur reparatur von gewebedefekten |
| JP2019520822A (ja) | 2016-06-16 | 2019-07-25 | アスペクト バイオシステムズ リミティド | バイオ印刷された半月板移植片及びその使用方法 |
| US10073346B2 (en) | 2016-07-08 | 2018-09-11 | Cypre, Inc. | Apparatus for patterning hydrogels into multi-well plates |
| WO2018013727A1 (en) | 2016-07-12 | 2018-01-18 | Deka Products Limited Partnership | System and method for applying force to a device |
| US11254901B2 (en) | 2016-07-12 | 2022-02-22 | Deka Products Limited Partnership | System and method for printing tissue |
| KR102207691B1 (ko) * | 2016-07-20 | 2021-01-26 | 와커 헤미 아게 | 3d 프린터 및 대상물의 제조 방법 |
| EP3490801B1 (de) * | 2016-07-27 | 2021-06-30 | President and Fellows of Harvard College | Vorrichtung und verfahren für akustophoretisches drucken |
| WO2018035282A1 (en) * | 2016-08-17 | 2018-02-22 | Nano-Dimension Technologies, Ltd. | Methods and libraries for use in inkjet bioprinting of biostructures |
| US11439731B2 (en) | 2016-09-14 | 2022-09-13 | Revotek Co., Ltd. | Artificial tissue progenitor and method for preparing the same |
| US11268950B2 (en) | 2016-09-28 | 2022-03-08 | Organovo, Inc. | Use of engineered renal tissues in assays |
| US11299705B2 (en) | 2016-11-07 | 2022-04-12 | Deka Products Limited Partnership | System and method for creating tissue |
| JP7300986B2 (ja) | 2016-11-10 | 2023-06-30 | オルガノボ インコーポレイテッド | 人工腸組織およびその使用 |
| CN110167609A (zh) | 2016-11-10 | 2019-08-23 | 奥加诺沃公司 | 生物打印的毛囊及其用途 |
| DE102016014946A1 (de) | 2016-12-14 | 2018-06-14 | Dürr Systems Ag | Druckkopf zur Applikation eines Beschichtungsmittels auf ein Bauteil |
| DE102016014943A1 (de) | 2016-12-14 | 2018-06-14 | Dürr Systems Ag | Druckkopf mit Temperiereinrichtung |
| DE102016014951A1 (de) | 2016-12-14 | 2018-06-14 | Dürr Systems Ag | Beschichtungseinrichtung und zugehöriges Betriebsverfahren |
| DE102016014948A1 (de) | 2016-12-14 | 2018-06-14 | Dürr Systems Ag | Druckkopf und zugehöriges Betriebsverfahren |
| DE102016014955A1 (de) | 2016-12-14 | 2018-06-14 | Dürr Systems Ag | Beschichtungseinrichtung und entsprechendes Beschichtungsverfahren |
| DE102016014944A1 (de) | 2016-12-14 | 2018-06-14 | Dürr Systems Ag | Beschichtungsverfahren und entsprechende Beschichtungseinrichtung |
| DE102016014947A1 (de) | 2016-12-14 | 2018-06-14 | Dürr Systems Ag | Druckkopf zur Applikation eines Beschichtungsmittels |
| DE102016014952A1 (de) | 2016-12-14 | 2018-06-14 | Dürr Systems Ag | Beschichtungseinrichtung zur Beschichtung von Bauteilen |
| DE102016014953A1 (de) | 2016-12-14 | 2018-06-14 | Dürr Systems Ag | Lackieranlage und entsprechendes Lackierverfahren |
| DE102016014956A1 (de) | 2016-12-14 | 2018-06-14 | Dürr Systems Ag | Beschichtungseinrichtung und zugehöriges Betriebsverfahren |
| KR101800249B1 (ko) | 2016-12-23 | 2017-12-20 | 주식회사 티앤알바이오팹 | 세포 프린팅 조성물의 혼합 장치 |
| US10261020B2 (en) * | 2017-01-04 | 2019-04-16 | Kaiser Optical Systems Inc. | Cost-effective Raman probe assembly for single-use bioreactor vessels |
| US10857260B2 (en) | 2017-01-12 | 2020-12-08 | The George Washington University | Coaxial needle for fabricating a multi scale, multi layer blood vessel or vascular network employing 3D bioprinting |
| SE542653C2 (en) * | 2017-01-13 | 2020-06-23 | Cellink Ab | A 3D bioprinter and a 3D bioprinter system |
| RU173439U1 (ru) * | 2017-01-19 | 2017-08-28 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Башкирский государственный университет" | Устройство для изготовления трехмерных прототипов с использованием растворов полимеров |
| WO2018153725A1 (en) * | 2017-02-22 | 2018-08-30 | Regenhu Ag | Tissue substitute printing |
| US10933579B2 (en) | 2017-03-10 | 2021-03-02 | Prellis Biologics, Inc. | Methods and systems for printing biological material |
| US11085018B2 (en) | 2017-03-10 | 2021-08-10 | Prellis Biologics, Inc. | Three-dimensional printed organs, devices, and matrices |
| MX2019010716A (es) * | 2017-03-10 | 2020-02-12 | Prellis Biologics Inc | Metodos y sistemas para imprimir material biologico. |
| US11864795B2 (en) * | 2017-04-02 | 2024-01-09 | Mazor Robotics Ltd. | Three dimensional robotic bioprinter |
| CA3058651A1 (en) | 2017-04-04 | 2018-10-11 | Allevi, Inc. | Multi-headed auto-calibrating bioprinter with heads that heat, cool, and crosslink |
| CN108790171A (zh) * | 2017-05-03 | 2018-11-13 | 上海幂方电子科技有限公司 | 一种可自动更换墨盒的3d打印设备 |
| GR1009361B (el) | 2017-05-11 | 2018-09-17 | Κωνσταντινος Ηλια Θεοδοσοπουλος | Συστημα παραγωγης μεσω τρισδιαστατης εκτυπωσης, δισκιων, κοκκιων και καψουλων |
| CN111032687A (zh) | 2017-05-25 | 2020-04-17 | 普瑞利思生物制品公司 | 三维打印的器官、设备和基质 |
| KR101957893B1 (ko) * | 2017-06-23 | 2019-06-27 | 주식회사 팡세 | 3d 프린팅용 조성물 및 이를 이용한 3d 프린터 |
| KR101957415B1 (ko) * | 2017-06-23 | 2019-03-12 | 주식회사 팡세 | 3d 프린팅용 조성물 및 이를 이용한 3d 프린팅 방법 |
| US10570362B2 (en) | 2017-07-12 | 2020-02-25 | Deka Products Limited Partnership | System and method for transferring tissue |
| KR102638609B1 (ko) * | 2017-07-27 | 2024-02-19 | 바이오메리욱스, 인코포레이티드. | 격리 튜브 |
| FR3069806B1 (fr) * | 2017-08-03 | 2019-08-23 | Centre National De La Recherche Scientifique | Tete d'impression d'une imprimante, imprimante et procede d'impression |
| CN107323089B (zh) * | 2017-08-10 | 2019-01-18 | 上海幂方电子科技有限公司 | 微电子打印机 |
| US11577469B2 (en) * | 2017-08-10 | 2023-02-14 | Shanghai Mi Fang Electronics Ltd. | 3D printer |
| US11262349B2 (en) | 2017-10-11 | 2022-03-01 | Cleveland State University | Multiplexed immune cell assays on a micropillar/microwell chip platform |
| CN107937981B (zh) * | 2017-11-17 | 2019-08-30 | 中国科学院新疆理化技术研究所 | 化合物氟硼酸锶及氟硼酸锶非线性光学晶体及制备方法和用途 |
| KR102645547B1 (ko) * | 2017-12-08 | 2024-03-11 | 인벤티아 라이프 사이언스 피티와이 엘티디 | 3d 세포 구성물을 제조하기 위한 바이오 프린터 |
| CN110001061A (zh) * | 2018-01-05 | 2019-07-12 | 天津职业技术师范大学 | 一种基于计算机图形设计办公自动化的大尺寸3d打印设备 |
| WO2019145795A2 (en) | 2018-01-26 | 2019-08-01 | Cellink Ab | Systems and methods for optical assessments of bioink printability |
| JP7367304B2 (ja) * | 2018-03-16 | 2023-10-24 | 株式会社リコー | 細胞組織体の製造方法 |
| US11097465B2 (en) | 2018-04-23 | 2021-08-24 | Io Tech Group Ltd. | Laser-based droplet array jetting of high viscous materials |
| US11872745B2 (en) * | 2018-06-22 | 2024-01-16 | 3D Systems, Inc. | Systems and methods for improved dispensing, layering, and deposition of cross-linkable hydrogels |
| US11491702B2 (en) | 2018-08-08 | 2022-11-08 | New Jersey Institute Of Technology | Additive manufacturing of channels |
| US11806444B2 (en) * | 2019-08-06 | 2023-11-07 | New Jersey Institute Of Technology | Additive manufacturing of cell-laden functional hydrogel and live cell constructs |
| US11426818B2 (en) | 2018-08-10 | 2022-08-30 | The Research Foundation for the State University | Additive manufacturing processes and additively manufactured products |
| TWI674201B (zh) * | 2018-09-10 | 2019-10-11 | 財團法人工業技術研究院 | 生物材料列印設備 |
| KR20220038806A (ko) * | 2018-09-25 | 2022-03-29 | 미라키 이노베이션 씽크 탱크 엘엘씨 | 의료용 스캐폴드 체내 로봇 이미징, 감지 및 배치 장치 및 사용 방법 |
| WO2020077118A1 (en) | 2018-10-10 | 2020-04-16 | Cellink Ab | Double network bioinks |
| KR102163075B1 (ko) * | 2018-10-10 | 2020-10-07 | 주식회사 클리셀 | 바이오 삼차원 프린터의 생체물질 항온을 위한 디스펜서부 워터 자켓 장치 및 그 장치의 멀티 온도 제어 방법 |
| US20200131471A1 (en) * | 2018-10-24 | 2020-04-30 | Postech Academy-Industry Foundation | Method of manufacturing cell spheroid using three-dimensional printing method |
| FR3087703B1 (fr) * | 2018-10-25 | 2020-12-04 | Poietis | Systeme de bio-impression robotise |
| KR102096510B1 (ko) * | 2018-11-15 | 2020-04-03 | 재단법인 대구경북과학기술원 | 3차원 바이오 프린터 장치 및 방법 |
| KR102191296B1 (ko) * | 2018-11-15 | 2020-12-15 | 한밭대학교 산학협력단 | 점도 특성이 상이한 접착제를 통해 비정형 건축물 제작이 가능한 하이브리드 바인더젯 3d 프린팅 장치 및 그 방법 |
| US20220118681A1 (en) * | 2018-12-06 | 2022-04-21 | Inventia Life Science Pty Ltd | Printhead Assembly for a 3D Bioprinter |
| CN109591290A (zh) * | 2018-12-29 | 2019-04-09 | 浙江大学滨海产业技术研究院 | 一种3d打印机针头与打印面定位装置及方法 |
| CN110014654A (zh) * | 2019-02-15 | 2019-07-16 | 上海幂方电子科技有限公司 | 一种可以支持自动更换和校准印刷头平面度和高度的装置 |
| US20240158727A1 (en) | 2019-03-06 | 2024-05-16 | Osaka University | Cell tissue production method, cell tissue production set, and cultivation container containing cell tissue produced by said production method |
| US11260601B2 (en) * | 2019-04-16 | 2022-03-01 | Brill, Inc. | System for printing binding agents |
| KR102249884B1 (ko) * | 2019-05-15 | 2021-05-12 | 삼영기계(주) | 적층 제어 시스템 및 방법 |
| CN110394985B (zh) * | 2019-06-21 | 2021-08-20 | 南京大学 | 一种利用Taylor喷射效应构造双层液锥进行三维连续分子自组装的装置及其方法 |
| US11826951B2 (en) | 2019-09-06 | 2023-11-28 | Cellink Ab | Temperature-controlled multi-material overprinting |
| AU2020396799A1 (en) * | 2019-12-06 | 2022-07-14 | Inventia Life Science Pty Ltd | Bioprinting system |
| CN111357787B (zh) * | 2020-04-01 | 2021-10-26 | 西京学院 | 一种蛋糕裱花3d打印系统 |
| SE544534C2 (en) * | 2020-05-12 | 2022-07-05 | Cellink Bioprinting Ab | Bioprinter and method for calibration of the bioprinter |
| US11938015B2 (en) * | 2020-05-21 | 2024-03-26 | International Business Machines Corporation | Bioprinted tissue with therapy capability |
| US20210379815A1 (en) * | 2020-06-09 | 2021-12-09 | 3D Systems, Inc. | Modular print bed for 3d bioprinter |
| WO2021257815A1 (en) * | 2020-06-18 | 2021-12-23 | University Of Virginia Patent Foundation | Digital assembly of spherical hydrogel voxels to form 3d lattice structures |
| JP7394732B2 (ja) * | 2020-10-19 | 2023-12-08 | Ｔｏｗａ株式会社 | 樹脂供給方法、樹脂成形品の製造方法及び樹脂成形装置 |
| BR202020025444U2 (pt) * | 2020-12-11 | 2021-06-08 | Dermyah Inovacoes Em Beleza E Bem Estar Ltda | bioimpressora 3d utilizando células tronco vegetais aplicada à recriação de tecido cutâneo para rejuvenescimento facial e biomáscara facial a partir de bioimpressão 3d |
| CN112873838B (zh) * | 2021-02-02 | 2022-04-05 | 中山大学 | 一种生物墨水打印条件筛选平台及筛选方法 |
| WO2022169451A1 (en) * | 2021-02-04 | 2022-08-11 | Hewlett-Packard Development Company, L.P. | Print cartridge registration systems |
| US11877398B2 (en) | 2021-02-11 | 2024-01-16 | Io Tech Group Ltd. | PCB production by laser systems |
| WO2022177496A1 (en) | 2021-02-17 | 2022-08-25 | Bico Group Ab | Bioprinting workflow systems and methods |
| US20240157629A1 (en) * | 2021-03-12 | 2024-05-16 | Hector Martinez | 3d bioprinter with continuous workflow capability |
| KR102514854B1 (ko) * | 2021-03-26 | 2023-03-28 | 연세대학교 산학협력단 | 바이오 잉크를 이용한 3d 프린터 및 이를 포함하는 미세 조직 구축 시스템 |
| US20220373462A1 (en) * | 2021-05-14 | 2022-11-24 | MBD Co., Ltd. | Measuring method of cell migration using the rate of cell invasion |
| CN114292743A (zh) * | 2021-11-25 | 2022-04-08 | 浙江大学 | 一种电场辅助下的打印装置、水凝胶微球的制备方法及应用 |
| WO2024048645A1 (ja) * | 2022-08-31 | 2024-03-07 | 公益財団法人川崎市産業振興財団 | キャピラリー近接検知方法およびキャピラリー近接検知装置 |
| ES2965778A1 (es) * | 2022-09-14 | 2024-04-16 | Voxelcare Sl | Equipo de impresión tridimensional mediante pellets |
Family Cites Families (119)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4759764A (en) | 1985-05-24 | 1988-07-26 | Clayton Foundation For Research | Peripheral nerve regeneration |
| US4808435A (en) | 1987-04-06 | 1989-02-28 | International Business Machines Corporation | Screen printing method for producing lines of uniform width and height |
| US5099090A (en) | 1988-05-11 | 1992-03-24 | Ariel Electronics, Inc. | Circuit writer |
| US6537567B1 (en) | 1997-07-03 | 2003-03-25 | Massachusetts Institute Of Technology | Tissue-engineered tubular construct having circumferentially oriented smooth muscle cells |
| US6401795B1 (en) | 1997-10-28 | 2002-06-11 | Sandia Corporation | Method for freeforming objects with low-binder slurry |
| US6316153B1 (en) | 1998-04-21 | 2001-11-13 | The University Of Connecticut | Free-form fabricaton using multi-photon excitation |
| US6697694B2 (en) | 1998-08-26 | 2004-02-24 | Electronic Materials, L.L.C. | Apparatus and method for creating flexible circuits |
| US7338798B2 (en) | 1998-09-15 | 2008-03-04 | The Regents Of The University Of Michigan | System and method for forming a cardiac muscle construct |
| DE69907397T2 (de) | 1999-02-17 | 2004-01-22 | Hewlett-Packard Co. (N.D.Ges.D.Staates Delaware), Palo Alto | Druckvorrichtung |
| US6979670B1 (en) | 1999-03-10 | 2005-12-27 | Biora Bioex Ab | Matrix protein compositions for grafting |
| US6642243B1 (en) | 1999-07-22 | 2003-11-04 | Ashkan Imanzahrai | Migraine medicine and method for treating same |
| JP2001145956A (ja) | 1999-11-19 | 2001-05-29 | Meiko:Kk | 光硬化性樹脂三次元造形物の積層造形装置及びその積層造形方法 |
| US6503273B1 (en) | 1999-11-22 | 2003-01-07 | Cyograft Tissue Engineering, Inc. | Tissue engineered blood vessels and methods and apparatus for their manufacture |
| US6454972B1 (en) | 1999-11-24 | 2002-09-24 | Sandia Corporation | Solid freeform fabrication using chemically reactive suspensions |
| US6520997B1 (en) | 1999-12-08 | 2003-02-18 | Baxter International Inc. | Porous three dimensional structure |
| US6315469B1 (en) | 2000-01-19 | 2001-11-13 | Hewlett-Packard Company | Tool and method for adjustment of printhead to platen spacing in a printer |
| DE10013223C2 (de) | 2000-03-13 | 2002-07-18 | Co Don Ag | Verfahren zur in vitro-Herstellung von dreidimensionalem, vitalem Knorpel- oder Knochengewebe und dessen Verwendung als Transplantationsmaterial |
| US20050091576A1 (en) | 2003-10-24 | 2005-04-28 | Microsoft Corporation | Programming interface for a computer platform |
| DE10018987A1 (de) | 2000-04-17 | 2001-10-31 | Envision Technologies Gmbh | Vorrichtung und Verfahren zum Herstellen von dreidimensionalen Objekten |
| WO2002004113A2 (en) | 2000-07-11 | 2002-01-17 | The Johns Hopkins University School Of Medicine | Methods of patterning protein and cell adhesivity |
| US7998735B2 (en) | 2000-08-21 | 2011-08-16 | Victorian Tissue Engineering Centre Pty. Ltd. | Vascularized tissue graft |
| US6561607B1 (en) | 2000-10-05 | 2003-05-13 | Eastman Kodak Company | Apparatus and method for maintaining a substantially constant closely spaced working distance between an inkjet printhead and a printing receiver |
| US6939489B2 (en) | 2001-03-23 | 2005-09-06 | Ivoclar Vivadent Ag | Desktop process for producing dental products by means of 3-dimensional plotting |
| WO2002085246A2 (en) | 2001-04-19 | 2002-10-31 | Case Western Reserve University | Fabrication of a polymeric prosthetic implant |
| DE10127225A1 (de) | 2001-05-22 | 2002-11-28 | Zeiss Carl | Ultraviolettlicht-Abschwächungsfilter |
| US20030049839A1 (en) | 2001-08-01 | 2003-03-13 | The University Of Texas System | Transparent multi-channel cell scaffold that creates a cellular and/or molecular gradient |
| US6986739B2 (en) | 2001-08-23 | 2006-01-17 | Sciperio, Inc. | Architecture tool and methods of use |
| US6934600B2 (en) | 2002-03-14 | 2005-08-23 | Auburn University | Nanotube fiber reinforced composite materials and method of producing fiber reinforced composites |
| US20100254900A1 (en) | 2002-03-18 | 2010-10-07 | Campbell Phil G | Biocompatible polymers and Methods of use |
| WO2003079985A2 (en) * | 2002-03-18 | 2003-10-02 | Carnegie Mellon University | Method and apparatus for preparing biomimetic scaffold |
| US6907307B2 (en) | 2002-07-02 | 2005-06-14 | 3D Systems, Inc. | Support volume calculation for a CAD model |
| WO2004006840A2 (en) | 2002-07-12 | 2004-01-22 | The Regents Of The University Of California | Three dimensional cell patterned bioploymer scaffolds and method of making the same |
| US6998264B2 (en) | 2002-11-19 | 2006-02-14 | Huntington Medical Research Institutes | Replication of biological tissue |
| US7641898B2 (en) | 2003-03-21 | 2010-01-05 | Materials Evolution And Development Usa, Inc. | Keratinocyte-fibrocyte concomitant grafting for wound healing |
| US20040197375A1 (en) | 2003-04-02 | 2004-10-07 | Alireza Rezania | Composite scaffolds seeded with mammalian cells |
| US7051654B2 (en) | 2003-05-30 | 2006-05-30 | Clemson University | Ink-jet printing of viable cells |
| CA2528134C (en) | 2003-06-04 | 2015-05-12 | University Of South Carolina | Tissue scaffold having aligned fibrils, apparatus and method for producing the same, and artificial tissue and methods of use thereof |
| JP4474858B2 (ja) | 2003-07-07 | 2010-06-09 | セイコーエプソン株式会社 | ギャップ調整装置、これに使用されるキャリブレーション用治具、およびギャップ調整装置を備えた液滴吐出装置、並びに電気光学装置の製造方法 |
| US20050074877A1 (en) | 2003-07-28 | 2005-04-07 | Mao Jeremy Jian | Biological engineering of articular structures containing both cartilage and bone |
| FR2859128B1 (fr) * | 2003-08-29 | 2006-03-10 | Centre Nat Rech Scient | Procede et dispositif de fabrication d'un composant multimateriaux tridimensionnel par impression du type jet d'encre |
| US8043614B2 (en) | 2004-03-09 | 2011-10-25 | Ahlfors Jan-Eric W | Autogenic living scaffolds and living tissue matrices: methods and uses thereof |
| DE10353281A1 (de) | 2003-11-14 | 2005-06-16 | Bayer Cropscience Ag | Wirkstoffkombination mit insektiziden und akariziden Eigenschaften |
| US20050276791A1 (en) | 2004-02-20 | 2005-12-15 | The Ohio State University | Multi-layer polymer scaffolds |
| WO2005081970A2 (en) | 2004-02-24 | 2005-09-09 | The Curators Of The University Of Missouri | Self-assembling cell aggregates and methods of making engineered tissue using the same |
| US20090142307A1 (en) | 2004-07-09 | 2009-06-04 | Athanasiou Kyriacos A | Shape-Based Approach for Scaffoldless Tissue Engineering |
| WO2007115337A2 (en) | 2006-04-05 | 2007-10-11 | William Marsh Rice University | Chondrocyte differentiation from human embryonic stem cells and their use in tissue engineering |
| US7625198B2 (en) | 2004-08-11 | 2009-12-01 | Cornell Research Foundation, Inc. | Modular fabrication systems and methods |
| US9723866B2 (en) * | 2004-08-11 | 2017-08-08 | Cornell University | System and method for solid freeform fabrication of edible food |
| US7651665B2 (en) | 2004-09-07 | 2010-01-26 | Hewlett-Packard Development Company, L.P. | Microtray for handling biosubstances |
| US7767446B2 (en) | 2004-09-16 | 2010-08-03 | Becton, Dickinson And Company | Perfusion bioreactors for culturing cells |
| KR100606457B1 (ko) | 2004-11-11 | 2006-11-23 | 한국기계연구원 | 3차원 프린팅 조형시스템 |
| JP4539316B2 (ja) | 2004-12-08 | 2010-09-08 | セイコーエプソン株式会社 | ヘッド位置補正方法およびヘッド位置補正装置、並びに液滴吐出装置、電気光学装置の製造方法 |
| US7568904B2 (en) | 2005-03-03 | 2009-08-04 | Laser Solutions Co., Ltd. | Stereolithography apparatus |
| JP4729948B2 (ja) | 2005-03-09 | 2011-07-20 | ブラザー工業株式会社 | 液体供給装置、この液体供給装置を備えたインクジェット記録装置 |
| US7780897B2 (en) | 2005-04-22 | 2010-08-24 | Board Of Regents, The University Of Texas System | Hydrogel constructs using stereolithography |
| WO2006127768A2 (en) | 2005-05-24 | 2006-11-30 | The Regents Of The University Of California | Microscale micropatterned engineered in vitor tissue |
| EP1934288A2 (de) | 2005-07-28 | 2008-06-25 | Carnegie Mellon University | Biokompatible polymere und verwendungsverfahren |
| US8690957B2 (en) | 2005-12-21 | 2014-04-08 | Warsaw Orthopedic, Inc. | Bone graft composition, method and implant |
| US8800482B2 (en) * | 2005-12-29 | 2014-08-12 | Exatec Llc | Apparatus and method of dispensing conductive material with active Z-axis control |
| US20070200276A1 (en) * | 2006-02-24 | 2007-08-30 | Micron Technology, Inc. | Method for rapid printing of near-field and imprint lithographic features |
| US7680555B2 (en) | 2006-04-03 | 2010-03-16 | Stratasys, Inc. | Auto tip calibration in an extrusion apparatus |
| US20070231787A1 (en) | 2006-04-04 | 2007-10-04 | Voelker Mark A | Methods and devices for imaging and manipulating biological samples |
| WO2007124481A2 (en) * | 2006-04-21 | 2007-11-01 | Drexel University | Bioprinting three-dimensional structures onto microscale tissue analog devices for pharmacokinetic study and other uses |
| US20090208466A1 (en) | 2006-04-21 | 2009-08-20 | James Yoo | Ink-jet printing of tissues |
| JP4051077B2 (ja) | 2006-04-28 | 2008-02-20 | シャープ株式会社 | 液滴塗布装置、液滴吐出部のギャップ測定方法、および、液滴吐出部のギャップ調整方法 |
| FR2901143B1 (fr) | 2006-05-16 | 2008-10-03 | Centre Nat Rech Scient | "methode de construction de materiaux vivants fonctionnels, materiaux obtenus et applications" |
| US7959942B2 (en) | 2006-10-20 | 2011-06-14 | Orbusneich Medical, Inc. | Bioabsorbable medical device with coating |
| DE102006053121B3 (de) | 2006-11-10 | 2007-12-27 | Eos Gmbh Electro Optical Systems | Vorrichtung und Verfahren zum Herstellen eines dreidimensionalen Objektes mittels eines Beschichters für pulverförmiges Aufbaumaterial |
| WO2008089449A2 (en) * | 2007-01-19 | 2008-07-24 | Biodot, Inc. | Systems and methods for high speed array printing and hybridization |
| US8097455B2 (en) | 2007-02-02 | 2012-01-17 | The Regents Of The University Of Michigan | System and method for forming skeletal muscle constructs having functional tissue interfaces |
| US8343740B2 (en) | 2007-03-29 | 2013-01-01 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Micro-organ device |
| CN101796186B (zh) | 2007-06-07 | 2013-05-22 | 韦克福里斯特大学健康科学院 | 喷墨基因打印 |
| WO2009013751A2 (en) | 2007-07-25 | 2009-01-29 | Objet Geometries Ltd. | Solid freeform fabrication using a plurality of modeling materials |
| EP2195131B1 (de) * | 2007-08-29 | 2011-10-26 | Vito NV | Verfahren zur herstellung einer dreidimensionalen makroporösen filamentkonstruktion auf grundlage von phasenumkehr und dadurch erhaltene konstruktion |
| US20090076531A1 (en) | 2007-09-18 | 2009-03-19 | Richardson Charles L | Method and apparatus for bypass graft |
| AU2008311957A1 (en) | 2007-10-15 | 2009-04-23 | Wake Forest University | Methods and compositions for printing biologically compatible nanotube composites of autologous tissue |
| US7923846B2 (en) | 2007-11-16 | 2011-04-12 | Stats Chippac Ltd. | Integrated circuit package-in-package system with wire-in-film encapsulant |
| JP2011514234A (ja) * | 2007-12-31 | 2011-05-06 | エグザテック・リミテッド・ライアビリティー・カンパニー | ３次元の物体上に印刷するための装置および方法 |
| KR100922232B1 (ko) | 2008-02-13 | 2009-10-16 | 연세대학교 산학협력단 | 전기수력학 프린팅 기법을 이용한 살아있는 세포의 직접패터닝 방법 및 장치 |
| EP2090584A1 (de) | 2008-02-13 | 2009-08-19 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Identifikation eines neuartigen Zystein-reichen Peptids zur Zellenpenetration |
| US8691274B2 (en) | 2008-02-14 | 2014-04-08 | Wake Forest University Health Sciences | Inkjet printing of tissues and cells |
| US20090248145A1 (en) | 2008-03-28 | 2009-10-01 | Nanyang Technological University | Method of forming a three-dimensional structure of unidirectionally aligned cells |
| US8876513B2 (en) | 2008-04-25 | 2014-11-04 | 3D Systems, Inc. | Selective deposition modeling using CW UV LED curing |
| HUE037881T2 (hu) | 2008-06-20 | 2018-09-28 | Univ Maastricht | Önrendezõdõ szövetmodulok |
| AU2009271223B2 (en) | 2008-06-24 | 2013-05-16 | The Curators Of The University Of Missouri | Self-assembling multicellular bodies and methods of producing a three-dimensional biological structure using the same |
| US9097702B2 (en) | 2008-07-29 | 2015-08-04 | Cornell University | Pathologically relevant tumor microenvironments for high-throughput drug screening |
| WO2010030964A2 (en) | 2008-09-12 | 2010-03-18 | The Brigham And Women's Hospital, Inc. | 3-dimensional multi-layered hydrogels and methods of making the same |
| DE102008057005A1 (de) * | 2008-11-11 | 2010-05-12 | Jonas & Redmann Automationstechnik Gmbh | Verfahren zum Positionieren und/oder Führen mindestens eines beliebigen Prozesskopfes für die Metallisierung von dünnen Substraten in einem definierten Abstand über der Substratoberfläche |
| US20110250688A1 (en) | 2008-11-24 | 2011-10-13 | Immunotrex Corporation | Three Dimensional Tissue Generation |
| US8691974B2 (en) | 2009-09-28 | 2014-04-08 | Virginia Tech Intellectual Properties, Inc. | Three-dimensional bioprinting of biosynthetic cellulose (BC) implants and scaffolds for tissue engineering |
| US8409603B2 (en) | 2009-10-01 | 2013-04-02 | University Of South Carolina | Compositions and methods for tissue engineering, tissue regeneration and wound healing |
| US20110177590A1 (en) * | 2009-12-11 | 2011-07-21 | Drexel University | Bioprinted Nanoparticles and Methods of Use |
| WO2011085225A1 (en) | 2010-01-08 | 2011-07-14 | Wake Forest University Health Sciences | Delivery system |
| US20130172985A1 (en) | 2010-01-15 | 2013-07-04 | University Of Utah Research Foundation | Crosslinked hydrogels and methods of making and using thereof |
| EP2531228A4 (de) | 2010-02-02 | 2013-08-14 | Univ Missouri | Herstellung eines manipulierten biologischen nerventransplantats und anwendung davon |
| US9039998B2 (en) | 2010-03-04 | 2015-05-26 | Institut National De La Sante Et De La Recherche Medical (Inserm) | Bioprinting station, assembly comprising such bioprinting station and bioprinting method |
| GB2478801B (en) | 2010-03-16 | 2012-05-30 | Organovo Inc | Multilayered vascular tubes |
| EP2552406B1 (de) | 2010-03-26 | 2018-01-24 | Stemmatters, Biotecnologia e Medicina Regenerativa, S.A. | Photovernetzte gellangummihydrogele: herstellungsverfahren und verwendungen davon |
| US9592255B2 (en) | 2010-07-01 | 2017-03-14 | The Regents Of The University Of Michigan | Scaffold-free three dimensional nerve fibroblast constructs |
| US20120089238A1 (en) | 2010-10-06 | 2012-04-12 | Hyun-Wook Kang | Integrated organ and tissue printing methods, system and apparatus |
| US9149952B2 (en) * | 2010-10-21 | 2015-10-06 | Organovo, Inc. | Devices, systems, and methods for the fabrication of tissue |
| HUE029316T2 (en) | 2010-11-04 | 2017-03-28 | Univ Of Pecs | Tüdõszövetmodell |
| DE202011003443U1 (de) | 2011-03-02 | 2011-12-23 | Bego Medical Gmbh | Vorrichtung zur generativen Herstellung dreidimensionaler Bauteile |
| WO2012122105A1 (en) | 2011-03-07 | 2012-09-13 | Wake Forest University Health Sciences | Delivery system |
| GB201105226D0 (en) | 2011-03-29 | 2011-05-11 | Univ Leiden | Methods |
| JP5599356B2 (ja) | 2011-03-31 | 2014-10-01 | 富士フイルム株式会社 | シミュレーション方法、プログラムおよびそれを記録した記録媒体、並びに、それらを利用した液滴配置パターンの作成方法、ナノインプリント方法、パターン化基板の製造方法およびインクジェット装置。 |
| US9126366B2 (en) * | 2011-06-15 | 2015-09-08 | Korea Institute Of Machinery & Materials | Apparatus and method for manufacturing cell culture scaffold |
| BR112014005752A2 (pt) | 2011-09-12 | 2017-03-28 | Organovo Inc | plataforma para tecidos e órgãos implantáveis produzidos por engenharia tecidual e métodos para sua produção |
| US20130190210A1 (en) | 2011-09-12 | 2013-07-25 | Organovo, Inc. | Engineered tissues for in vitro research uses, arrays thereof, and methods of making the same |
| US10059056B2 (en) | 2012-02-01 | 2018-08-28 | Nscrypt, Inc. | Micro-dispensing multi-layered 3D objects with curing steps |
| US10072257B2 (en) | 2012-02-29 | 2018-09-11 | Massachusetts Institute Of Technology | Inverse patterning process for three-dimensional multi-compartmental micro-organization of multiple cell types |
| KR20140142278A (ko) | 2012-03-06 | 2014-12-11 | 더 유에이비 리서치 파운데이션 | 삼차원, 예비맥관화, 조작 조직 구조체, 조직 구조체의 제조 방법 및 사용 방법 |
| US9499779B2 (en) | 2012-04-20 | 2016-11-22 | Organovo, Inc. | Devices, systems, and methods for the fabrication of tissue utilizing UV cross-linking |
| US20140099709A1 (en) | 2012-06-19 | 2014-04-10 | Organovo, Inc. | Engineered three-dimensional connective tissue constructs and methods of making the same |
| US20140046473A1 (en) | 2012-08-08 | 2014-02-13 | Makerbot Industries, Llc | Automated model customization |
| JP2016522312A (ja) | 2013-03-15 | 2016-07-28 | マターファブ, コーポレイションMatterfab Corp. | 添加剤製造装置及び方法のためのカートリッジ |
| US9442105B2 (en) | 2013-03-15 | 2016-09-13 | Organovo, Inc. | Engineered liver tissues, arrays thereof, and methods of making the same |
| US9802360B2 (en) | 2013-06-04 | 2017-10-31 | Stratsys, Inc. | Platen planarizing process for additive manufacturing system |
| DK3028042T3 (da) | 2013-07-31 | 2021-10-04 | Organovo Inc | Automatiserede anordninger, systemer og fremgangsmåder til fremstilling af væv |
-
2014
- 2014-07-30 DK DK14832338.9T patent/DK3028042T3/da active
- 2014-07-30 BR BR112016002149A patent/BR112016002149A2/pt not_active IP Right Cessation
- 2014-07-30 CA CA2919734A patent/CA2919734C/en active Active
- 2014-07-30 EP EP14832338.9A patent/EP3028042B1/de active Active
- 2014-07-30 JP JP2016531871A patent/JP6842918B2/ja active Active
- 2014-07-30 US US14/447,412 patent/US20150037445A1/en not_active Abandoned
- 2014-07-30 AU AU2014296246A patent/AU2014296246B2/en active Active
- 2014-07-30 SG SG11201600770RA patent/SG11201600770RA/en unknown
- 2014-07-30 CN CN201480054148.1A patent/CN105659089B/zh active Active
- 2014-07-30 WO PCT/US2014/048962 patent/WO2015017579A1/en active Application Filing
- 2014-07-30 KR KR1020167005277A patent/KR20160036619A/ko active IP Right Grant
-
2015
- 2015-07-10 US US14/796,910 patent/US9315043B2/en active Active
-
2017
- 2017-03-27 US US15/470,531 patent/US20170199507A1/en not_active Abandoned
-
2020
- 2020-04-30 US US16/863,018 patent/US20210008788A1/en not_active Abandoned
- 2020-12-04 JP JP2020202047A patent/JP2021061839A/ja not_active Withdrawn
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6991218B2 (ja) | 2016-12-14 | 2022-01-12 | デュール システムズ アーゲー | 塗布装置及びコーティング組成物を塗布する方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20210008788A1 (en) | Automated devices, systems, and methods for the fabrication of tissue | |
| US11577451B2 (en) | Bioprinter for the fabrication of tissue | |
| US10174276B2 (en) | Devices, systems, and methods for the fabrication of tissue utilizing UV cross-linking | |
| JP2016526910A5 (de) | ||
| AU2016253591A1 (en) | Devices, systems, and methods for the fabrication of tissue |